Medicare Enrolled
Dr. Martin Glowacki, M.D.
Interventional Pain Medicine Physician · Troy, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glowacki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glowacki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glowacki
Dr. Martin Glowacki is an interventional pain medicine physician in Troy, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Glowacki performed 4,299 Medicare services across 1,966 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glowacki received a total of $5,352 from 34 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glowacki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in MI
$5,352 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,299
Medicare services
Top 8% in MI for interventional pain medicine physician
1,966
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
858 | $94 | $200 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
405 | $12 | $125 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
352 | $0 | $75 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
337 | $9 | $200 |
| Injection, methylprednisolone acetate, 40 mg | 230 | $6 | $40 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
205 | $9 | $50 |
| Injection, fentanyl citrate, 0.1 mg | 179 | $1 | $50 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
173 | $36 | $200 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
145 | $189 | $750 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
145 | $86 | $375 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
145 | $0 | $100 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
139 | $201 | $600 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
130 | $372 | $700 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
129 | $196 | $500 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
123 | $155 | $700 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
123 | $82 | $350 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
72 | $191 | $600 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
62 | $206 | $700 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
57 | $355 | $800 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $133 | $400 |
| New patient office visit, complex (60-74 min) | 48 | $168 | $500 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
46 | $56 | $300 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
42 | $138 | $800 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
42 | $77 | $400 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
22 | $1 | $50 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
19 | $76 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $67 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,352
Total received (2018-2024)
Avg $765/year across 7 years
Top 32% in MI for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,049 (57.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,303 (43.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$324
2023
$659
2022
$243
2021
$506
2020
$264
2019
$622
2018
$2,734
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$112
ABBVIE INC.
$110
Nevro Corp.
$83
Galderma Laboratories, L.P.
$19
Top 3 companies account for 94.2% of 2024 payments
All-time payments by company (2018-2024) ›
Arthrex, Inc.
$2,303
Nevro Corp.
$469
Amgen Inc.
$368
Collegium Pharmaceutical, Inc.
$289
ABBVIE INC.
$272
Scilex Pharmaceuticals Inc.
$171
BOSTON SCIENTIFIC CORPORATION
$156
Takeda Pharmaceuticals U.S.A., Inc.
$126
Medtronic, Inc.
$120
BioDelivery Sciences International, Inc.
$117
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$88
Virtus Pharmaceuticals LLC
$80
PFIZER INC.
$78
Flexion Therapeutics, Inc.
$64
SCILEX PHARMACEUTICALS INC.
$63
Allergan, Inc.
$62
Teva Pharmaceuticals USA, Inc.
$60
Biohaven Pharmaceutical Holding Company Ltd.
$53
Stimwave Technologies Incorporated
$50
Saluda Medical Americas, Inc.
$38
Galderma Laboratories, L.P.
$36
Allergan Inc.
$30
Sentynl Therapeutics, Inc.
$30
Boston Scientific Corporation
$29
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$29
Daiichi Sankyo Inc.
$29
Bioventus LLC
$27
RedHill Biopharma Inc.
$24
Stryker Corporation
$17
Abbott Laboratories
$17
Nalu Medical, Inc.
$15
Purdue Pharma L.P.
$14
Horizon Therapeutics plc
$14
Medtronic USA, Inc.
$13
Top 3 companies account for 58.7% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AJOVY · Aimovig · Amitiza · BELBUCA · BOTOX · BOTOX COSMETIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · DYSPORT · Durolane · Evoke SCS · GENERAL PAIN MANAGEMENT · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · LEVORPHANOL TARTRATE · LYRICA · Levorphanol · Levorphanol Tartrate · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · Omnia · PENNSAID · PROCLAIM · QULIPTA · RELISTOR · RELISTOR ORAL · SPECTRA WAVEWRITER · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Supartz · UBRELVY · VRAYLAR · XIFIXAN · XTAMPZA · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
20
Per 100K population
1.6
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL, TROY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glowacki is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glowacki experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Glowacki performed 858 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glowacki receive payments from pharmaceutical companies?
Yes. Dr. Glowacki received a total of $5,352 from 34 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glowacki's costs compare to other interventional pain medicine physicians in Troy?
Dr. Glowacki's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glowacki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Troy
Browse interventional pain medicine physicians in Troy ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in MI
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in MI
Which MI interventional pain medicine physicians receive the most from drug and device companies.
By company
Arthrex, Inc. Payments to Doctors
See all physicians who received payments from Arthrex, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology